Lynch Syndrome: The Gene Result Is Never Askable

If you have a confirmed Lynch syndrome result and a life insurance application in front of you, here is the clean answer that most articles bury under hedging: a UK insurer cannot ask you for that predictive gene result, at any sum assured. Lynch syndrome and life insurance is a question people expect to be complicated, and the genetics part is not. Just one condition can ever be asked about on a UK application, and Lynch is not it.

That single condition is Huntington's disease, and even then only for life cover above a set figure. Every other predictive genetic result — a Lynch fault included — sits outside what an insurer is allowed to request or use, regardless of how much cover you apply for. So the raw fact that you carry a Lynch mismatch-repair fault is not something you have to declare, and not something an insurer may ask for.

What is a fair question is the medical history that can come with Lynch: a cancer you have actually had, the colonoscopies you attend, any surgery. Those are ordinary medical facts, disclosable if the application asks. The skill is in keeping the two apart — the protected gene result on one side, your genuine medical history on the other — so you answer accurately without handing over the thing the rules keep off the form.

Which "Lynch" you actually have

Lynch syndrome is not a cancer. It is an inherited fault in one of the genes that repair mistakes in DNA — the mismatch-repair genes — and carrying that fault raises the lifetime risk of certain cancers, most notably bowel and, in women, womb cancer. That is the crucial distinction the insurance rules turn on: carrying the fault is a risk, not an illness.

So the word "Lynch" can mean two very different things on an application. It can mean the predictive gene result: you were tested, while well, and found to carry the family's fault. That result is protected. Or it can mean a cancer that has actually developed, whether or not it was the event that led to the Lynch fault being identified in the first place. That is medical history, and it is a different question with a different answer.

Even where the Lynch fault was confirmed after a cancer — the tumour was tested, and a germline test followed — the gene result still describes your future risk of further cancers, which is what makes it a predictive result under the rules. The cancer you had is disclosable. The gene status behind it is not. Getting comfortable with that split is most of the battle, and it mirrors the way BRCA is handled, which we set out in BRCA: the result they cannot ask you for.

Appendix lists one condition, and Lynch is not it

The rule that governs all of this is the Code on Genetic Testing and Insurance, an agreement between the government and the insurance industry. Its central commitment is that an insurer will not ask you to take a predictive genetic test, and will not require or use the result of one when deciding whether to offer cover or on what terms.

The Code has an appendix listing the results an insurer may ever ask about, and it contains a single entry: Huntington's disease. For a predictive Huntington's result, an insurer may ask only where the total life cover applied for is more than £500,000. Nothing else appears on that list. Lynch syndrome is not there, at any level of cover, so a predictive Lynch result cannot be asked for or used, however large the policy.

Source: HM Government and the Association of British Insurers, Code on Genetic Testing and Insurance.

This is where so much online advice misleads UK readers, because it is written for countries where life insurers can use genetic results. Here they cannot, save for that one listed condition above the threshold. The practical upshot is that the genetics rarely bite at all — our piece on why most life policies never reach the genetic testing threshold shows just how narrow the exception is.

What is disclosable: cancer, colonoscopies, surgery

The protection covers the gene result. It does not cover your medical history, and this is where accuracy matters.

If a Lynch-related cancer has actually developed and been treated, that diagnosis is ordinary medical history and has nothing to do with the genetics rules. An insurer is entitled to ask about diagnoses, investigations and treatment, and you must answer those questions. Underwriting after a cancer depends heavily on the type, the stage, how long ago it was and how you have been since — being through treatment is not seen the same way as being many years clear.

The surveillance that comes with Lynch is disclosable too, if asked. Applications commonly ask about hospital investigations, tests and procedures, and a GP report obtained with your consent would show your colonoscopies. Declaring that you attend regular colonoscopies is not the same as handing over the gene result: you are answering about medical care you have received, which is permitted, rather than disclosing the predictive test, which is not. Any surgery — bowel surgery, or risk-reducing gynaecological surgery some women with Lynch choose — is an operation, and operations are disclosable if the form asks about them.

What Lynch surveillance involves

It is worth understanding the surveillance, both because it may come up on a form and because it is the whole point of knowing you have Lynch in the first place. The value of the diagnosis is not that it frightens you; it is that it puts you inside a programme designed to catch cancer early or prevent it.

The mainstay is regular colonoscopy, typically every two years from a set age that depends on which mismatch-repair gene is involved, because the different genes carry different risks and different starting ages. Alongside that, aspirin is often discussed, as there is evidence it reduces bowel cancer risk in people with Lynch. For women, there is a separate conversation about womb and ovarian cancer risk, screening, and sometimes risk-reducing surgery once a family is complete. NHS clinical genetics services coordinate all of this. You can read a clear overview from the NHS and more on the condition from Cancer Research UK. Being in surveillance is the good outcome — it is how an inherited risk becomes a managed one.

Answering the application accurately

Underneath everything sits the Consumer Insurance (Disclosure and Representations) Act 2012, which sets out what you owe an insurer. It does not ask you to volunteer every fact you can think of. It asks you to take reasonable care not to make a misrepresentation — to answer the questions you are actually asked, honestly and carefully.

Read against Lynch, that means three things. Answer the medical questions fully: any cancer, any surgery, your colonoscopies and other investigations. Do not offer up the predictive gene result, which the insurer is not permitted to ask for. And if it happens that you were tested and found not to carry the family's fault, that favourable result is one you are allowed to volunteer if it helps you, though you never have to. Get the medical answers right and there is nothing about a Lynch result that should trouble a future claim; get them wrong and a claim can be challenged. If you are ever unsure whether a decision leaned on something protected, the route to question it is mapped through our family history, inherited risk and the odds hub.

A word too on the direct-to-consumer angle, because some people first learn of a Lynch-associated risk through a shop-bought DNA kit rather than the NHS. A predictive result from such a kit is protected in exactly the same way as a clinical one, a point we cover in whether you must declare a 23andMe result to a life insurer. The source of the test does not change the protection.

Getting cover, and not skipping the test

People with Lynch syndrome do get life cover. What an underwriter weighs is the medical picture — any cancer history, how it was treated, your surveillance and general health — not the protected gene result. Decisions vary between insurers, which is exactly why comparing matters, and why it is worth doing through someone who understands the genetics rules rather than guessing on a comparison site.

You can get life insurance quotes and have an FCA-authorised broker approach it in the right order, so your medical history is answered accurately and the gene result stays where the Code puts it — off the form. And it is worth knowing that many life policies carry a terminal illness benefit that can pay early on a qualifying diagnosis, a feature we look at in the context of another inherited condition in motor neurone disease in the family and the benefit inside a life policy.

One thing you should not do is delay or decline a clinically useful genetic test to protect an insurance application. The result cannot be asked for anyway, and testing is what unlocks the surveillance that can catch a cancer early or prevent it. That trade-off is almost never worth making, and we set out why in full in why you should not skip a Lynch test to protect your insurance.

Scotland and Northern Ireland

The insurance rules are the same across the United Kingdom. The Code on Genetic Testing and Insurance is an industry-wide agreement, so a predictive Lynch result cannot be asked for or used in Scotland or Northern Ireland any more than in England and Wales, Huntington's above £500,000 aside. The Consumer Insurance (Disclosure and Representations) Act 2012 applies UK-wide too, so the same reasonable-care standard governs how you answer the medical questions wherever you live.

What can differ is the clinical pathway: how NHS genetics services are organised, the exact ages and intervals used for colonoscopy surveillance, and how bowel cancer screening programmes run in each nation. Those affect your medical history and the care you are offered, not the insurance rule itself. Wherever you are in the UK, the same clean answer holds: the gene result is never askable, and your genuine medical history is what an insurer assesses.

Frequently asked questions

Does Lynch syndrome have to be declared for life insurance?

A predictive gene result does not. The appendix to the Code on Genetic Testing and Insurance lists Huntington's disease alone, so no Lynch result may be asked for at any sum assured. Symptoms, a cancer diagnosis, colonoscopies and surgery are separate, and are disclosable if the application asks about them. You keep the gene result off the form and answer the medical questions accurately.

What surveillance does Lynch syndrome involve?

Regular colonoscopy, usually every two years from a set age depending on which gene is involved, plus consideration of aspirin and, for women, discussion of gynaecological risk and surgery. NHS clinical genetics services coordinate this, and it is the main practical benefit of knowing you carry a Lynch fault, because it is aimed at catching cancer early or preventing it.

Will the colonoscopies show up on an application?

They can. Applications commonly ask about investigations, hospital tests and treatment, and a GP report obtained with your consent would show them. You are answering about medical care you have received, which is permitted, rather than handing over the gene result, which is not. Answer those questions accurately and the protected result still stays off the form.